Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
| Actual shortage: | 243 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUININE | 300MG | CAPSULE | Resolved | 2017-09-04 | 2018-04-17 | 20894 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2017-11-01 | 2018-01-13 | 27735 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-09 | 2017-12-19 | 28726 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2017-11-28 | 2018-01-10 | 30938 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-12-12 | 2018-01-26 | 32520 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-01-03 | 2018-01-18 | 34826 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-02-01 | 2018-04-24 | 37980 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-12 | 42681 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2018-04-02 | 2018-08-21 | 44497 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2018-05-15 | 2018-09-11 | 49367 |
| APO-IRBESARTAN | 300MG | TABLET | Resolved | 2018-05-15 | 2018-09-11 | 49408 |
| APO-IRBESARTAN | 300MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55810 |
| APO-TENOFOVIR | 300MG | TABLET | Resolved | 2018-07-25 | 2018-09-04 | 56538 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-07-31 | 2018-09-28 | 56989 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2018-08-09 | 2018-10-26 | 57779 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-11-16 | 2019-01-23 | 67019 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2019-01-30 | 2019-02-13 | 74014 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2019-02-06 | 2019-04-25 | 74867 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-05 | 2019-11-05 | 77872 |
| APO-IBUPROFEN | 300MG | TABLET | Resolved | 2019-06-05 | 2021-01-11 | 85597 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-DIPYRIDAMOLE | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
| APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |